Filing Details
- Accession Number:
- 0000315066-16-005625
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-02-18 14:00:38
- Reporting Period:
- 2016-02-17
- Filing Date:
- 2016-02-18
- Accepted Time:
- 2016-02-18 14:00:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1445283 | Proteostasis Therapeutics Inc. | PTI | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 315066 | Fmr Llc | 245 Summer Street Boston MA 02210 | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-02-17 | 925,051 | $0.00 | 1,318,932 | No | 4 | C | Indirect | F-Prime Capital Partners Healthcare Fund II LP |
| Common Stock | Acquisiton | 2016-02-17 | 183,880 | $0.00 | 1,502,812 | No | 4 | C | Indirect | F-Prime Capital Partners Healthcare Fund II LP |
| Common Stock | Acquisiton | 2016-02-17 | 375,000 | $8.00 | 1,877,812 | No | 4 | P | Indirect | F-Prime Capital Partners Healthcare Fund II LP |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | F-Prime Capital Partners Healthcare Fund II LP |
| No | 4 | C | Indirect | F-Prime Capital Partners Healthcare Fund II LP |
| No | 4 | P | Indirect | F-Prime Capital Partners Healthcare Fund II LP |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Convertible Preferred Stock | Disposition | 2016-02-17 | 10,000,000 | $0.00 | 925,051 | $0.00 |
| Common Stock | Series B Convertible Preferred Stock | Disposition | 2016-02-17 | 1,987,782 | $0.00 | 183,880 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- On February 17, 2016, in connection with the completion of the issuer's initial public offering, all shares of Convertible Preferred Stock converted into shares of Common Stock at a 10.8102-for-one conversion ratio.
- Includes 393,881 shares of Common Stock issued as payment of accrued dividends upon conversion of the Series A Convertible Preferred Stock on February 17, 2016.
Billionaire Hedge Funds
